President Uhuru Kenyatta has welcomed the selection of Kenya as a beneficiary of the global messenger ribonucleic acid (mRNA) technology transfer program. Speaking after the announcement by World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus, President Kenyatta appreciated the gesture saying it “demonstrates the power of partnerships to change the trajectory of Africa’s health for the better.” In 2021, Kenya expressed interest for the establishment of a technology transfer hub for mRNA vaccines in the country. “Today marks a new dawn of hope and promise for the Afric…